SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

EID Parry rises on plan to merge Parry Phytoremedies with itself

31 Jul 2014 Evaluate

E.I.D. Parry (India) is currently trading at Rs. 197.70, up by 1.35 points or 0.69% from its previous closing of Rs. 196.35 on the BSE.

The scrip opened at Rs. 193.20 and has touched a high and low of Rs. 197.90 and Rs. 193.20 respectively. So far 5812 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 229.90 on 23-Jun-2014 and a 52 week low of Rs. 103.00 on 07-Aug-2013.

Last one week high and low of the scrip stood at Rs. 202.45 and Rs. 188.40 respectively. The current market cap of the company is Rs. 3445.41 crore.

The promoters holding in the company stood at 45.22% while Institutions and Non-Institutions held 27.44% and 27.30% respectively.

EID Parry India has received an approval for amalgamation of Parry Phytoremedies, a wholly owned subsidiary company with itself, subject to various regulatory and other approvals. The board of directors at its meeting held on July 30, 2014 has approved for the same.

Parry Phytoremedies, being a wholly owned subsidiary of the company and the entire equity share capital of Parry Phyto being held by the company, there will be no issue of equity shares by the transferee company pursuant to the amalgamation.

EID Parry India manufactures and markets a wide range of products such as sugar, bio-products and nutraceuticals. Today, the company is one of the Top 5 sugar producers in India and is on the path to sweetening more lives around the world.

E.I.D. Parry (I) Share Price

865.45 12.45 (1.46%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×